<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rao SD</submitter><funding>Pew Charitable Trusts</funding><funding>NIAID NIH HHS</funding><funding>Marie-Josée Kravis Women in Science Endeavor (WISE) fellowship</funding><funding>NCI NIH HHS</funding><funding>Gabrielle’s Angel Foundation for Cancer Research</funding><funding>U.S. Department of Health &amp;amp; Human Services | National Institutes of Health</funding><funding>NIGMS NIH HHS</funding><funding>Mr. William H and Mrs. Alice Goodwin, the Commonwealth Foundation for Cancer Research, and The Center for Experimental Therapeutics of Memorial Sloan Kettering Cancer Center; the Emerson Collective</funding><pagination>565-574</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9179932</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(5)</volume><pubmed_abstract>Inflammasomes are multiprotein complexes that sense intracellular danger signals and induce pyroptosis. CARD8 and NLRP1 are related inflammasomes that are repressed by the enzymatic activities and protein structures of the dipeptidyl peptidases 8 and 9 (DPP8/9). Potent DPP8/9 inhibitors such as Val-boroPro (VbP) activate both NLRP1 and CARD8, but chemical probes that selectively activate only one have not been identified. Here we report a small molecule called CQ31 that selectively activates CARD8. CQ31 inhibits the M24B aminopeptidases prolidase (PEPD) and Xaa-Pro aminopeptidase 1 (XPNPEP1), leading to the accumulation of proline-containing peptides that inhibit DPP8/9 and thereby activate CARD8. NLRP1 is distinct from CARD8 in that it directly contacts DPP8/9's active site; these proline</pubmed_abstract><journal>Nature chemical biology</journal><pubmed_title>M24B aminopeptidase inhibitors selectively activate the CARD8 inflammasome.</pubmed_title><pmcid>PMC9179932</pmcid><funding_grant_id>T32 GM007739</funding_grant_id><funding_grant_id>N/A</funding_grant_id><funding_grant_id>T32 GM007739-Andersen</funding_grant_id><funding_grant_id>P30 CA008748</funding_grant_id><funding_grant_id>R01 AI163170</funding_grant_id><funding_grant_id>R25AI140472</funding_grant_id><funding_grant_id>T32 GM115327-Tan</funding_grant_id><funding_grant_id>R25 AI140472</funding_grant_id><funding_grant_id>T32 GM115327</funding_grant_id><funding_grant_id>R01 AI137168</funding_grant_id><funding_grant_id>F30 CA243444</funding_grant_id><funding_grant_id>F30 CA008748</funding_grant_id><pubmed_authors>Cross JR</pubmed_authors><pubmed_authors>Chen Q</pubmed_authors><pubmed_authors>Griswold AR</pubmed_authors><pubmed_authors>Rao SD</pubmed_authors><pubmed_authors>You S</pubmed_authors><pubmed_authors>Ball DP</pubmed_authors><pubmed_authors>Chui AJ</pubmed_authors><pubmed_authors>Covelli DJ</pubmed_authors><pubmed_authors>Bhattacharjee A</pubmed_authors><pubmed_authors>Wang Q</pubmed_authors><pubmed_authors>Orth-He EL</pubmed_authors><pubmed_authors>Saoi M</pubmed_authors><pubmed_authors>Bachovchin DA</pubmed_authors><pubmed_authors>Huang HC</pubmed_authors></additional><is_claimable>false</is_claimable><name>M24B aminopeptidase inhibitors selectively activate the CARD8 inflammasome.</name><description>Inflammasomes are multiprotein complexes that sense intracellular danger signals and induce pyroptosis. CARD8 and NLRP1 are related inflammasomes that are repressed by the enzymatic activities and protein structures of the dipeptidyl peptidases 8 and 9 (DPP8/9). Potent DPP8/9 inhibitors such as Val-boroPro (VbP) activate both NLRP1 and CARD8, but chemical probes that selectively activate only one have not been identified. Here we report a small molecule called CQ31 that selectively activates CARD8. CQ31 inhibits the M24B aminopeptidases prolidase (PEPD) and Xaa-Pro aminopeptidase 1 (XPNPEP1), leading to the accumulation of proline-containing peptides that inhibit DPP8/9 and thereby activate CARD8. NLRP1 is distinct from CARD8 in that it directly contacts DPP8/9's active site; these proline</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2026-05-10T06:50:54.773Z</modification><creation>2025-02-19T03:25:55.457Z</creation></dates><accession>S-EPMC9179932</accession><cross_references><pubmed>35165443</pubmed><doi>10.1038/s41589-021-00964-7</doi></cross_references></HashMap>